Upadacitinib offers long-term benefits against treatment-resistant moderate-to-severe atopic dermatitisJuly 24, 2023Atopic Dermatitis
Dupilumab rapidly reduces Staphylococcus aureus abundance in moderate-to-severe atopic dermatitisJuly 24, 2023Atopic Dermatitis
Atopic dermatitis not associated with malignancy overall but increases the risk for lymphomaJuly 24, 2023Atopic Dermatitis
Lebrikizumab shows favorable benefit-risk profile in adolescents with moderate-to-severe atopic dermatitisJuly 24, 2023Atopic Dermatitis
Phase 3 trial supports long-term efficacy and safety of abrocitinib in moderate-to-severe atopic dermatitisJuly 24, 2023Atopic Dermatitis
Dermatology NewsFDA approves cantharidin for molluscum contagiosumJuly 24, 2023Medical DermatologyPediatricsInfectious Diseases
Dermatology NewsStudy examines pediatric skin biopsy trends at a tertiary care centerJuly 21, 2023PediatricsMedical Dermatology
Dermatology NewsWhat makes teens choose to use sunscreen?July 21, 2023Nonmelanoma Skin CancerPediatricsMelanomaMixed Topics
Dermatology NewsWhen treating AD in children, experts consider adherence, other aspects of treatmentJuly 21, 2023Atopic DermatitisPediatrics
Dermatology NewsOcular complications of dermatologic treatments: Advice from a pediatric ophthalmologistJuly 21, 2023Atopic DermatitisPediatrics
Dermatology NewsRising patient costs tied to private equity ownershipJuly 21, 2023Business of MedicinePractice Management
Dermatology NewsCase report describes pediatric RIME triggered by norovirusJuly 20, 2023PediatricsInfectious DiseasesRare Diseases
